28 Current news of Merck

rss

image description
Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

23-09-2014

Merck and Sigma-Aldrich announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will acquire all of the outstanding ...

more

Merck on Track with Pharma Strategy

Pipeline Progress Announced

22-09-2014

Merck announced that its biopharmaceutical division Merck Serono is well on track with the implementation of the Group’s “Fit for 2018” transformation and growth program. This is reflected by efficiency gains and the successful execution of growth initiatives as well as progress in the pipeline, ...

more

Merck Serono’s President has been appointed to Board of Directors of L’Oréal

23-04-2014

Merck Serono announced that Belén Garijo, President & Chief Executive Officer of Merck Serono, has been appointed asan independent Director of L’Oréal for a period of four years. The appointment of Belén Garijo as a new member of the Board of Directors ofL’Oréal was approved by shareholders at ...

more

Merck Millipore and VWR Extend Western European Distribution Agreement

10-04-2014

Merck Millipore, the Life Science division ofMerck, announced a new non-exclusive, preferred distribution agreement for Western Europe with VWR a global provider of laboratory supplies, equipment and services. The contract includes a range of Merck Millipore products and reagents for chemical ...

more

Allergopharma plans to invest € 40 million in production facility

16-12-2013

Merck broke ground on a new production facility for its Allergopharma unit in Reinbek near Hamburg. The new facility, which is estimated to cost nearly € 40 million, will be used, among other things, to expand production to serve new markets such as China. In the two-story building, which will be ...

more

Merck’s new spin-off to focus on infertility treatment

04-12-2013

Merck Serono announced the creation of TocopheRx, a Boston-based spin-off company resulting from its Entrepreneur Partnership Program (EPP) launched in April 2012. TocopheRx, the 8th spin-off in the EPP will focus on the development of oral follicle-stimulating hormone (FSH) agonists for ...

more

Merck Serono’s Grant for Growth Innovation

Countdown for accepting proposals

05-11-2013

Merck Serono announced that there is just one month remaining for researchers leading innovative research projects to apply for grants as part of the Merck Serono Grant for Growth Innovation (GGI) which was launched in September. Grants totalling up to 400,000 € will be awarded to one or more ...

more

Merck Serono announces partnership with the Lead Discovery Center

01-11-2013

Merck Serono announced a five-year strategic partnership with the Lead Discovery Center GmbH (LDC), Dortmund, Germany, a translational research organization. This collaboration integrates the expertise and resources of both organizations to expedite the discovery of promising lead structures and ...

more

Gerhard Schmitz to join Merck as new Head of Global Accounting

31-10-2013

Merck announced that Gerhard Schmitz (50) will join the pharmaceutical, chemical and life science company as new Head of Global Accounting from Nov. 1, 2013. Gerhard Schmitz joins Merck from Lanxess, where he was Head of Accounting. “We’re pleased that with Gerhard Schmitz we’ve won an ...

more

Merck Serono and Selvita announce research collaboration in cancer

28-10-2013

Merck Serono and Selvita announced that they have entered into a collaboration to jointly discover small molecule based drugs targeting proteins involved in cancer cell metabolism. The partners plan to target key metabolic pathways involved in sustaining growth and proliferation of cancer ...

more

Page 1 From 3
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE